However, unlike other tumour-suppressor genes that are typically deleted, truncated, silenced, or otherwise downregulated, the majority of p53 alterations are missense mutations in the DNA-binding domain, often leading to a high constitutive expression of mutant p53 in tumour cells (Sigal and Rotter, 2000). The gene discussed is TP53; the disease is neoplasm.